search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    ACADIA Pharmaceuticals Inc.

    (NASDAQ:ACAD)

    $14.09

    $-0.13

    -0.91%

    ACADIA Pharmaceuticals Inc. Chart

    ACAD Stock Price Today

    ACADIA Pharmaceuticals Inc. (ACAD) stock declined over -0.91% intraday to trade at $14.09 a share on NASDAQ. The stock opened with a gain of 0.36% at $14.03 and touched an intraday high of $14.31, falling -0.91% against the last close of $14.22. The stock went to a low of $13.95 during the session.

    Stock Snapshot

    $14.22

    Prev. Close

    2.23 Billion

    Market Cap

    $13.95

    Day Low

    $14.03

    Open

    161.23 Million

    Number of Shares

    $14.31

    Day High

    -

    P/E ratio

    -1.33

    EPS (TTM)

    3.23

    Cash Flow per Share

    8.04

    Free Float in %

    3.53

    Book Value

    1,592,185

    Volume

    ACADIA Pharmaceuticals Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$14.03$14.31$13.95$14.091,577,837
    2022-06-29$14.04$14.37$13.89$14.221,844,600
    2022-06-28$14.62$14.72$13.87$142,721,400
    2022-06-27$14.88$15.25$14.6$14.642,365,100
    2022-06-24$14.84$15.48$14.35$14.983,829,500
    2022-06-23$13.44$14.86$13.38$14.725,568,000
    2022-06-22$12.75$13.61$12.68$13.435,888,800
    2022-06-21$13.2$13.26$12.24$13.0122,269,000
    2022-06-17$19.51$19.51$19.51$19.510
    2022-06-16$18.53$20.35$17.89$19.517,927,500

    Contact Details

    12830 El Camino Real
    Suite 400
    San Diego, CA 92130
    United States

    Webiste:ACAD

    858 558 2871

    Company Information

    Employees-

    Beta0.7

    Sales or Revenue484.14 Million

    5Y Sales Change94.60%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

    Frequently Asked Questions

    icon

    What is the current ACADIA Pharmaceuticals Inc. (ACAD) stock price?

    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock price is $14.09 as of the last check on Thursday, June 30. During the trading session, ACAD stock reached the peak price of $14.31 while $13.95 was the lowest point it dropped to.

    icon

    ACAD's industry and sector of operation?

    The NASDAQ listed ACAD is part of Biotechnology industry that operates in the broader Health Care sector. ACADIA Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

    icon

    Who are the executives of ACAD?

    Mr. James K. Kihara
    VP, Corp. Controller & Principal Accounting Officer
    Dr. Kathie M. Bishop Ph.D.
    Sr. VP, Chief Scientific Officer & Head of Rare Disease
    Mr. Stephen R. Davis J.D.
    CEO & Director
    Dr. Srdjan R. Stankovic M.D., M.S.P.H.
    Pres

    icon

    What is the ACAD stock price today?

    ACAD stock traded closed the last session at $14.09, which is $-0.13 or -0.91% lower than its previous close of $14.22. ACAD's current trading price is 15.11% lower than its 52-week high of $28.06 where as its distance from 52-week low of 12.24% is -49.78%.

    icon

    How many employees does ACAD have?

    Number of ACAD employees currently stands at -. ACAD operates from 12830 El Camino Real, Suite 400, San Diego, CA 92130, United States.

    icon

    Link for ACAD official website?

    Official Webiste of $ACAD is: https://www.acadia-pharm.com

    icon

    How do I contact ACAD?

    ACAD could be contacted at ACAD operates from 12830 El Camino Real, Suite 400, San Diego, CA 92130, United States, or at phone #858 558 2871 and can also be accessed through its website.

    icon

    How many shares of ACAD are traded daily?

    ACAD stock volume for the day was 1,592,185 shares while in the previous session number of ACAD shares traded was 1,577,837 . The average number of ACAD shares traded daily for last 3 months was 2.64 Million.

    icon

    How much did ACAD change today?

    The percentage change in ACAD stock occurred in the recent session was -0.91% while the dollar amount for the price change in ACAD stock was $-0.13.

    icon

    What price range ACAD stock been trading in?

    In the recent session, the day high for ACAD stock was $14.31 while the low for ACAD stock touched on the day was $13.95.

    icon

    What is the market cap of ACAD currently?

    The market value of ACAD currently stands at 2.23 Billion with its latest stock price at $14.09 and 161.23 Million of its shares outstanding.